Partnervest Advisory Services’s GSK GSK Stock Holding History

Partnervest Advisory Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-221	Closed	-$15K	–	409
2014 Q2	$15K	Sell	221 -78	-26%	-$5.28K	0.01%	605
2014 Q1	$20K	Buy	299 +81	+37%	+$5.48K	0.01%	503
2013 Q4	$15K	Sell	218 -1,256	-85%	-$81.4K	0.01%	540
2013 Q3	$92K	Buy	1,474 +1	+0.1%	+$64	0.05%	203
2013 Q2	$92K	Buy	+1,473	New	+$93.5K	0.04%	165

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Partnervest Advisory Services's GSK Position: Q3 2014 in Review

Partnervest Advisory Services sold out of GSK (GSK) in Q3 2014, closing a stake of 221 shares — an estimated $15K sold.

Partnervest Advisory Services first reported a position in GSK in Q2 2013 and held it in 5 quarters. The position peaked at $92K in Q3 2013. 701 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

Partnervest Advisory Services reported no remaining GSK position as of Q3 2014 after selling out during the quarter.
Partnervest Advisory Services sold 221 GSK shares in Q3 2014, an estimated $15K.
Partnervest Advisory Services first reported a position in GSK in Q2 2013 and held it in 5 quarters.
Partnervest Advisory Services's GSK position peaked at $92K in Q3 2013.
701 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on Partnervest Advisory Services's 13F filing for Q3 2014, filed 7 Nov 2014.